Effects of sildenafil citrate on defibrillation efficacy

Journal of Cardiovascular Electrophysiology

Volumn 17, Issue 3, 2006, Pages 292-295

  Shinlapawittayatorn, Krekwit ^a,b   Sungnoon, Rattapong ^a,b   Chattipakorn, Siriporn ^b   Chattipakorn, Nipon ^a,b  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Defibrillation; Sildenafil citrate; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL PROTOCOL; CONVULSIVE THERAPY; DEFIBRILLATION; DRUG EFFECT; DRUG INFUSION; FEMALE; HEART VENTRICLE FIBRILLATION; HYPOTHESIS; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; THERAPY EFFECT;

ANIMALS; BLOOD PRESSURE; ELECTRIC COUNTERSHOCK; HEART RATE; INFUSIONS, INTRAVENOUS; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; SWINE; VENTRICULAR FIBRILLATION;

EID: 33644782031     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00348.x     Document Type: Article

References (34)

1. Boolell M Allen MJ Ballard SA Gepi-Attee S Muirhead GJ Naylor AM Osterloh IH Gingell C Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction Int J Impot Res 1996 8 47 52
2. Goldstein I Lue TF Padma-Nathan H Rosen RC Steers WD Wicker PA Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group N Engl J Med 1998 338 1397 1404
3. Moreland RB Goldstein I Traish A Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells Life Sci 1998 62 L 18
4. Park K Moreland RB Goldstein I Atala A Traish A Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle Biochem Biophys Res Commun 1998 249 612 617
5. Zusman RM Morales A Glasser DB Osterloh IH Overall cardiovascular profile of sildenafil citrate Am J Cardiol 1999 83 35C 44C
6. Kloner RA Jarow JP Erectile dysfunction and sildenafil citrate and cardiologists Am J Cardiol 1999 83 576 582 A7
7. Kloner RA Cardiovascular risk and sildenafil Am J Cardiol 2000 86 57F 61F
8. Geelen P Drolet B Rail J Berube J Daleau P Rousseau G Cardinal R O'Hara GE Turgeon J Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current Circulation 2000 102 275 277
9. Shakir SA Wilton LV Boshier A Layton D Heeley E Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England BMJ 2001 322 651 652
10. Swissa M Ohara T Lee MH Kaul S Shah PK Hayashi H Chen PS Karagueuzian HS Sildenafil-nitric oxide donor combination promotes ventricular tachyarrhythmias in the swine right ventricle Am J Physiol Heart Circ Physiol 2002 282 H1787 H1792
11. Bharani A Mathew V Sahu A Lunia B The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension Indian Heart J 2003 55 55 59
12. Bhatia S Frantz RP Severson CJ Durst LA McGoon MD Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy Mayo Clin Proc 2003 78 1207 1213
13. Kothari SS Duggal B Chronic oral sildenafil therapy in severe pulmonary artery hypertension Indian Heart J 2002 54 404 409
14. Michelakis ED Tymchak W Noga M Webster L Wu XC Lien D Wang SH Modry D Archer SL Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension Circulation 2003 108 2066 2069
15. Chattipakorn N Banville I Gray RA Ideker RE Mechanism of ventricular defibrillation for near-defibrillation threshold shocks: A whole-heart optical mapping study in swine Circulation 2001 104 1313 1319
16. Boddicker KA Zhang Y Zimmerman MB Davies LR Kerber RE Hypothermia improves defibrillation success and resuscitation outcomes from ventricular fibrillation Circulation 2005 111 3195 3201
17. Chattipakorn N KenKnight BH Rogers JM Walker RG Walcott GP Rollins DL Smith WM Ideker RE Locally propagated activation immediately after internal defibrillation Circulation 1998 97 1401 1410
18. Chattipakorn N Fotuhi PC Ideker RE Prediction of defibrillation outcome by epicardial activation patterns following shocks near the defibrillation threshold J Cardiovasc Electrophysiol 2000 11 1014 1021
19. Rhee BJ Zhang Y Boddicker KA Davies LR Kerber RE Effect of hypothermia on transthoracic defibrillation in a swine model Resuscitation 2005 65 79 85
20. Jackson G Benjamin N Jackson N Allen MJ Effects of sildenafil citrate on human hemodynamics Am J Cardiol 1999 83 13C 20C
21. Alpaslan M Onrat E Samli M Dincel C Sildenafil citrate does not affect QT intervals and QT dispersion: An important observation for drug safety Ann Noninvasive Electrocardiol 2003 8 14 17
22. Kaya D Guler C Esen AM Barutcu I Dincel C Sildenafil citrate does not alter ventricular repolarization properties: Novel evidence from dynamic QT analysis Ann Noninvasive Electrocardiol 2004 9 228 233
23. Nagy O Hajnal A Parratt JR Vegh A Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24 h after oral administration in dogs Br J Pharmacol 2004 141 549 551
24. Shah PK Sildenafil in the treatment of erectile dysfunction N Engl J Med 1998 339 699 702
25. Sugiyama A Satoh Y Shiina H Takahara A Yoneyama M Hashimoto K Cardiac electrophysiologic and hemodynamic effects of sildenafil, a PDE5 inhibitor, in anesthetized dogs J Cardiovasc Pharmacol 2001 38 940 946
26. Vardi Y Bulus M Reisner S Nassar S Aboud L Sprecher E Gruenwald I Effects of sildenafil citrate (Viagra) on hemodynamic parameters during exercise testing and occurrence of ventricular arrhythmias in patients with erectile dysfunction and cardiovascular disease Eur Urol 2003 43 544 551
27. Cheitlin MD Hutter AM Jr. Brindis RG Ganz P Kaul S Russell RO Jr. Zusman RM ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association J Am Coll Cardiol 1999 33 273 282
28. Chiang CE Luk HN Wang TM Ding PY Effects of sildenafil on cardiac repolarization Cardiovasc Res 2002 55 290 299
29. Umans JG Levi R Nitric oxide in the regulation of blood flow and arterial pressure Annu Rev Physiol 1995 57 771 790
30. Musialek P Lei M Brown HF Paterson DJ Casadei B Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current, I(f) Circ Res 1997 81 60 68
31. Beavo JA Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms Physiol Rev 1995 75 725 748
32. Ishikura F Beppu S Hamada T Khandheria BK Seward JB Nehra A Effects of sildenafil citrate (Viagra) combined with nitrate on the heart Circulation 2000 102 2516 2521
33. Kleinsasser A Loeckinger A Hoermann C Puehringer F Mutz N Bartsch G Lindner KH Sildenafil modulates hemodynamics and pulmonary gas exchange Am J Respir Crit Care Med 2001 163 339 343
34. Cheitlin MD Hutter AM Jr. Brindis RG Ganz P Kaul S Russell RO Jr. Zusman RM Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee Circulation 1999 99 168 177